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Abstract
Quality sleep is critical for daily functions of human beings and thus the timing and
duration of sleep are tightly controlled. However, rare genetic variants affecting sleep
regulatory mechanisms can result in sleep phenotypes of extremely deviated
sleep/wake onset time or duration. Using genetic analyses in families with multiple
members expressing particular sleep phenotypes, these sleep-associated genetic vari-
ants can be identified. Deciphering the nature of these genetic variants using animal
models or biochemical methods helps further our understanding of sleep processes.
In this chapter, we describe the methods for studying genetics of human sleep behav-
ioral phenotypes.
1. INTRODUCTION
Life has evolved to adapt the 24-h cycle of the earth spinning on its
axis, using the cycling environmental cues (zeitgebers) to set daily activities
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at the appropriate time of the day. This daily rhythm helps maximize the
well-being of living organisms, and disruptions of the timing and duration
for specific daily activities, such as sleep, are disadvantageous to survival.
Sleep is controlled by circadian rhythms (process C) and homeostatic regu-
lation (process S; Borbely & Achermann, 1999). The circadian clock con-
solidates sleep to a defined period of day, while sleep homeostasis manages
the amount of sleep so that sufficient attention, and cognitive and motor
functions are maintained while awake. Accordingly, these two processes
together determine when we sleep and how long we need to sleep.
Although sleep is one of the most ancient and fundamental biological
processes across the animal kingdom, its function and regulation remain
obscure. It is known, nevertheless, that sufficient and consolidated sleep
of good quality is crucial for proper physical and cognitive performance
in the vigilant awake state. Adverse effects due to sleep deprivation or cir-
cadian desynchrony include increased risks of a spectrum of health problems
from obesity (Roenneberg, Allebrandt,Merrow, &Vetter, 2012) and cancer
(Haus & Smolensky, 2013) to psychiatric disorders (Colten, Altevogt, &
Institute of Medicine (U.S.). Committee on Sleep Medicine and
Research, 2006). Alarming epidemiologic data show a steady decrease of
nightly sleep duration in American adults over that past 50 years (Colten
et al., 2006; Kraus & Rabin, 2012) and a significant discrepancy of sleep
duration between work days and nonwork days (social sleep deprivation;
Roenneberg et al., 2012). It is estimated that 50–70 million of people chron-
ically suffer from sleep-related problems in the United States alone (Colten
et al., 2006), and long-term burden of these sleep pathologies is conceivably
enormous.
In light of the prevalence of sleep problems, there is a pressing need for
the development of remedies through better understanding of sleep pro-
cesses. Major breakthroughs in our knowledge of the molecular control
of sleep timing and homeostasis have come through studies of familial
advanced sleep phase (FASP) and familial natural short sleep (FNSS; He
et al., 2009; Jones et al., 1999; Toh et al., 2001; Xu et al., 2005, 2007). FASP
and FNSS are Mendelian autosomal dominant sleep phenotypes that signif-
icantly deviate from the population norm and run within families. Advanced
sleep phase (ASP) phenotype is characterized by spontaneous early sleep and
wake onset time, while the total amount of sleep and sleep quality are not
affected if the subject is not forced to adapt to a nonideal sleep schedule by
social or work obligations. The natural short sleep (NSS) phenotype, on the
other hand, is characterized by shortened sleep duration per day, while the
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time of sleep onset is not changed. Unlike control subjects, NSS subjects do
not report sleep deprivation despite their shortened duration of sleep. Fur-
ther investigating the molecular genetics of these naturally occurring human
sleep variations promises unprecedented insights into mechanisms and reg-
ulation of sleep. In this regard, we aim to comprehensively outline here the
procedures and methods in studying FASP and FNSS, from phenotyping
FASP and FNSS kindreds (Section 2), identification of genetic variants
(Section 3) to modeling in rodents (Section 4).
2. CLINICAL PHENOTYPING
2.1. Overview
The first step in studying the genetics of FASP and FNSS is to reliably iden-
tify the individuals with sleep phenotypes of interest. There are three major
challenges in rigorously distinguishing these individuals from the general
population. First, while sleep is an essential function and a drastic deviation
from the population mean (e.g., 2 h of sleep per day) is highly unlikely, there
is a range of phenotypic variation in sleep onset time and sleep duration, sim-
ilar to other quantitative traits such as height and weight. Second, contrary to
neurological or psychiatric disorders with defined diagnostic criteria, cur-
rently identifying FASP and FNSS depends mainly on arbitrary thresholds
for early sleep onset and short sleep duration, respectively. This makes
the diagnosis of Mendelian sleep phenotype difficult when they are heavily
based on self-reported or indirect physiological data from only a few days
(see below). Lastly, sleep behavior is easily influenced by environmental
and social factors which interfere with intrinsic or natural preferences of
sleep and wake-up time. Therefore, extreme caution should be taken in
phenotyping the probands and their relatives in order to identify families
with FASP or FNSS to facilitate follow-up studies. In this section, we
describe current methods for clinically phenotyping human subjects with
potential FASP or FNSS.
2.2. Methods
2.2.1 Recruitment and sampling of potential affected subjects
There are two ways to recruit potential affected subjects—referral by clini-
cians and self-referral. Since ASP and short sleep phenotypes do not typically
interfere with daily lives of affected individuals, they are often overlooked
by both the affected individuals and professional clinicians. In the future,
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a better awareness of the importance of sleep and sleep problems will lead to
better identification and increased research participation from affected
individuals.
One key to successfully identifying genetic variants of sleep phase or
sleep duration with stronger effect size is to select probands with relatively
large deviations from the population mean. For the ASP phenotype, we
focus on individuals that have tendency to sleep before 8:30 pm and to
wake-up spontaneously before 5:30 am. These individuals should have
comparable quantity and quality of sleep to control subjects. For the short
sleep phenotype, we select affected individuals that require less than 6.5 h
of sleep per night, with normal sleep onset time. It should be noted that a
significant portion of the population exhibit “social sleep deprivation” (also
called “social jetlag” in the original report) on their workdays due to work
and/or social obligations (Roenneberg et al., 2012). However, as opposed to
natural short sleepers, those individuals tend to make up for their sleep debt
during nonworkdays, and they also have stronger sleep drive during the day
(Roenneberg, 2013). In addition, in order to validate advance sleep phase or
short sleep as primary phenotypes rather than the secondary effects of other
health conditions or medication, it is imperative to have an experienced cli-
nician assess the general health and clinical history of each potential proband
before recruitment and investigation of their kindred.
Although ASP and short sleep phenotypes often run in families, it should
be noted that the proband may have a de novomutation, and there is no other
member in the family that shares the phenotype. This is considered a spo-
radic case and it may be more challenging to unequivocally identify the
causal genetic variant until future generations are established. In addition,
sleep phenotypes in some individual may be recessive or genetically com-
plex. In these cases, extended families have to be characterized before the
mode of inheritance can be determined. With appropriate informed con-
sent, family members of the proband will be phenotypically assessed using
self-reports and structured interviews, and by data from physiological mea-
surements of circadian rhythms.
2.2.2 Self-reports and interviews
Several questionnaires are designed to differentiate innate sleeping patterns
apart from the influence of environmental factors such as social and work
obligations, and seasonal variations. The most commonly used are the
Horne–Ostberg Morning–Eveningness Questionnaire (Horne & Ostberg,
1976) and the Munich Chronotype Questionnaire (Roenneberg,
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Wirz-Justice, & Merrow, 2003), both of which inquire about the actual and
ideal (as represented during a vacation) sleep patterns. For the assessment of
ASP phenotype, the peak time of alertness, an indicator of circadian rhythm
preference, is also assessed to estimate the possibility of an altered or mis-
aligned circadian rhythm, as this is highly probable in cases of FASP.
In determining the short sleep phenotype, it is important to consider that
a significant portion of people who work a full-time job are chronically sleep
deprived during work days. These individuals tend to sleep more during the
nonwork days to make up for the sleep debt (Roenneberg, 2013;
Roenneberg et al., 2012). Since the degree of sleep deprivation varies among
individuals, the Epworth Sleepiness Scale or Karolinska Sleepiness Scale is
useful in gauging whether a person is actually getting enough sleep
(Akerstedt & Gillberg, 1990; Johns, 2002). Along this line, to deduce the
amount of sleep required, the total amount of sleep during a stretch of time
by physiological measurements (see Section 2.2.3) may be a more reliable
measure than the self-reported “typical” sleep pattern.
To further exclude the possibility that sleep behavior is under the influ-
ence of pharmacological or other environmental factors, interviews of sub-
jects by an experienced clinician are conducted. In the interviews, the
clinician intends to identify if any medical conditions or pharmaceutical
agents modify the sleep pattern. Sleep apnea, narcolepsy, depression, and
other neuropsychological disorders are known to affect sleep patterns,
whereas a wide spectrum of over-the-counter drugs (e.g., melatonin), pre-
scription drugs (e.g., SSRI; Ferguson, 2001), and commonly consumed
foods and beverages (e.g., coffee, alcohol) modulate alertness/sleepiness
levels and evenmodulate the structure of sleep. However, it should be noted
that certain medical conditions can be comorbid with sleep phenotypes,
possibly because the sleep-related variants result in multiple conditions
simultaneously. For example, in a FASP kindred, the CSNK1D T44A
variant that reduces the activity of casein kinase 1δ was shown to cause both
FASP and migraine (Brennan et al., 2013; Xu et al., 2005). Alternatively,
sleep-related variants may cosegregate with the variants associated with
other medical conditions, thus resulting in comorbidity of sleep phenotypes
with these conditions. Therefore, extreme caution should be taken in
determining whether the ASP and short sleep are the genuine primary phe-
notypes, independent of other disorders or pharmaceutical agents.
Furthermore, entrainment is known to shift the intrinsic clock,
depending on the time of day the entrainment cue (zeitgeber) is given
(Khalsa, Jewett, Cajochen, & Czeisler, 2003). In the case of FASP, the
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possible involvement of light, the most important and pervasive environ-
mental cue, has to be considered (Munch & Bromundt, 2012). In particular,
seasonal variations of daylight duration may result in varying wake-up time
throughout the year. In a similar fashion, exposure to artificial light in the
living environment early in the morning induces advancement in wake
onset. Information about lighting in sleeping environments and seasonal
variations in sleep–wake patterns will help rule out major confounding
effects of light on sleep phenotypes.
2.2.3 Physiological measurements for circadian rhythm
To support subjective self-reported data, objective measurements of circa-
dian cycles and sleep patterns need to be taken. Since one of the potential
causes of the ASP phenotype is a shortened circadian cycle (Roenneberg
et al., 2003; Xu et al., 2007), it will be ideal to have research subjects in a
constant environment with only dim light and isolated from outside cues
(free running) for days to determine the intrinsic circadian period (τ; see
Section 4.2 for determination of τ in rodents) (Kleitman & Kleitman,
1953). Another method to measure τ is to uncouple the sleep/wake cycle
and the circadian cycle by forcing the subject into 20 or 28 h of rest/activity
schedule by dim light (forced desynchrony protocols; Dijk, Duffy, Riel,
Shanahan, & Czeisler, 1999). After 2 weeks, the timing of sleep falls uni-
formly across every circadian phase, thus the effects of other zeitgebers
are minimized. τ can be reliably determined in this method. The constant
routine protocol was developed to track the timing of biological markers
(e.g., core body temperature or plasma melatonin levels) of circadian time
in constant setting for 40 h (Duffy &Dijk, 2002). Besides estimating τ, chro-
notypes as reflected by the phase relationship between sleep onset and time
of day (phase angle or ψ ) can be deduced. Obtaining chronotype informa-
tion from biological markers will help evaluate the ASP phenotype. Overall
these methods are very useful but also substantially time and resource con-
suming, and impractical to apply to every subject. As an alternative, saliva
samples collected under dim light before sleep are analyzed to give an esti-
mate of the onset of melatonin synthesis (Lewy, 2007). Dim light melatonin
onset (DLMO) thus derived is a reliable phase marker and is expected to shift
forward in FASP individuals relative to normal control.
Besides circadian influence, sleep is regulated by the sleep homeostatic
process (process S). This is particularly important regarding the determina-
tion of the short sleep phenotype, which is likely due to a change in the
homeostatic aspect of sleep. To inspect sleep/activity patterns, actigraphy,
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sleep logs, and electroencephalography (EEG) can be exploited. In practice,
wrist actimetry sensors and home EEG units that are compatible to daily life
are worn for about 2 weeks or more to obtain accurate measures of
sleep/wake time and sleep length (He et al., 2009; Hughes, 1990; Jones
et al., 1999). EEG data are particular informative, as information about
the intensity, frequency, timing, and duration of various brain activities
offers to definitively mark the sleep/wake transition and to assess the quality
of sleep. In this regard, slow wave activity (0.5–4 Hz) during nonrapid eye
movement (NREM) sleep, as reflected by δ power, is a good indicator of
sleep depth and sleep drive (process S; Dijk, Beersma, & van den
Hoofdakker, 1989). The overall amount of δ power during sleep per day
is thought to be constant for each individual. Consequently, δ power is
increased in rebound sleep after sleep deprivation and is decreased in night-
time sleep for individuals who take naps during the day (Dijk & Beersma,
1989; Dijk, Beersma, & Daan, 1987; Huber, Deboer, & Tobler, 2000).
Hypothetically, the short sleep phenotype could result from an efficient
homeostatic process during sleep. Therefore, FNSS individuals could have
comparable accumulative δ activity during a night of sleep to that of control
individuals. It is plausible that other distinct characteristics of sleep structure,
such as an altered ratio of NREM/total sleep time, differentiate FNSS
individuals from controls. Further studies will help to test this possibility.
3. IDENTIFICATION OF ASSOCIATED GENETIC VARIANTS
3.1. Overview
Kindreds with FASP and FNSS offer golden opportunities to pinpoint the
genetic elements underlying human sleep behaviors. Identifying the specific
genetic variants responsible for sleep phenotypes will promise to broaden
our understanding of sleep regulation in similar ways essential components
of many diseases were revealed (Fu et al., 1991, 1992; Karayiorgou et al.,
1995; Ptacek et al., 1991; Xu, Hsu, Stark, Karayiorgou, & Gogos, 2013).
From the forward genetics point of view, this approach also resembles
how the circadian mechanisms were originally delineated in flies and mice
(Konopka & Benzer, 1971; Vitaterna et al., 1994). As with these forward
genetic studies in model organisms, it is believed that by focusing on phe-
notypes with a Mendelian (autosomal dominant) mode of inheritance,
researchers will be able to identify key components controlling sleep sched-
ule and duration/homeostasis. Since FASP and FNSS are relatively rare
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(C. Jones, unpublished data), the causative genetic variants are likely rare
variants with large effect size (in determining the sleep phenotype).
3.2. Methods
3.2.1 Collecting DNA samples
DNA samples are collected from as many members in the kindred as possible
in order to facilitate genetic analyses. Conventionally, to obtain high quan-
tity and quality of DNA, the gold standard is to obtain samples through phle-
botomy (Toh et al., 2001; Xu et al., 2005). DNAwith optimal quality can be
extracted by PAXgene Blood DNA Kit (QIAGEN), GeneCatcher gDNA
Blood Kit (Invitrogen), or NucleoSpin Blood (MACHEREY-NAGEL). It
is advantageous to obtain as much DNA as possible (>200 μg) to avoid
repeated sampling from the same subjects.
A less invasive alternative is to obtain buccal swab and extract DNA using
QuickExtract DNA Extraction Solution (Illumina). This method is rela-
tively quick and generates PCR-ready DNA samples; however, the total
yield is limited (1–7 μg), which may be problematic for certain applications
such as next-generation sequencing (NGS).
Recent advancement in stem cell research makes it possible to generate
and propagate induced pluripotent stem cells (iPSCs) from skin biopsy or
urine samples (containing exfoliated renal epithelial cells; Takahashi et al.,
2007; Yu et al., 2007; Zhou et al., 2012). DNA can then be extracted from
iPSC cultures for use in genetic analyses. However, it should be noted that
the reprogramming procedure can induce de novo genomic alterations such
as copy-number variation (CNV; Hussein et al., 2011). Also, it is currently
time and money consuming to generate human iPSCs. Consequently, for
the sole purpose of isolating DNA for genetic analysis, this approach is
not recommended.
3.2.2 Mapping the locations of the associated genetic variants by
linkage analysis
Traditionally, for autosomal dominant Mendelian disorders, linkage analysis
can be performed in a large family with multiple affected individuals. During
meiosis, recombination happens randomly across chromosomes. Therefore,
the closer the disease variant and a genetic marker (microsatellite or SNP) are
on the chromosome, the higher the chances that they will cosegregate (link-
age) into the next generation (Strachan & Read, 1999). Based on this prop-
erty, linkage analysis can track the association of genetic markers and
phenotypes to deduce the locus (or loci) that harbors the variants associated
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with FASP or FNSS (Toh et al., 2001). In practice, logarithm of odds (lod)
score is calculated by comparing the likelihood of linkage and no linkage,
and a lod score higher than 3 is an accepted threshold for linkage. The devel-
opment of high-density single nucleotide polymorphism (SNP) arrays (e.g.,
GeneChip Array or Genome-Wide Human SNP array) has made it possible
to analyze large and complex pedigrees and to define the susceptibility loci to
smaller areas (Middeldorp et al., 2007; Sellick et al., 2004). However, the
exact nature of the genetic variant cannot be uncovered by linkage analysis
alone and needs to be determined by sequencing.
3.2.3 Identify the associated genetic variants
Once the loci are defined, researchers need to sequence the loci for specific
genetic variant(s) that contribute to the phenotype. For identifying SNPs or
indels (small insertion or deletion), Sanger sequencing or various NGS plat-
forms (e.g., SOLiD, Ion Torrent, HiSeq) can be exploited (El-Metwally,
Ouda, & Helmy, 2014). These methods have their distinct advantages
and disadvantages. For example, Sanger sequencing is not suitable for
detecting large deletions since sequencing reads may not cross the deletion
boundaries. Additionally, Sanger sequencing and exome sequencing primar-
ily focus on uncovering variants in the exons of protein-coding genes and
consequently miss most if not all of the intronic mutations or variants in
regulatory RNA-coding genes. The choice of specific method has to
be decided based on the nature of the genomic regions of interest, time,
and budget.
Accumulating evidence has shown the involvement of CNVs in deter-
mining susceptibility of various disorders (Wheeler et al., 2013; Zhang, Gu,
Hurles, & Lupski, 2009). Although large CNVs that encompass many genes
(e.g., 22q11.2 microdeletions) can cause several aberrant symptoms (Drew
et al., 2011), CNVs affecting only a few genes are prevalent in the human
population (Pinto, Marshall, Feuk, & Scherer, 2007; Redon et al., 2006) and
may contribute to various sleep phenotypes. Traditionally, CNVs can be
detected by fluorescence in situ hybridization and comparative genomic
hybridization. The availability of high-density SNP array makes it possible
to do linkage analysis and CNV detection simultaneously. Most recently,
development of computational tools enables detection of CNV in NGS data
sets by approaches such as paired-end mapping and read-depth analysis, thus
making NGS an attractive way of detecting variants across the whole size
spectrum from SNPs to CNVs.
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In a majority of the kindreds identified thus far, definite genotype and
phenotype data are only available from a small number of members due
to the difficulty to recruit and inspect the extended family. These kindreds
usually only include two to three affected individuals, making linkage anal-
ysis impractical or inconclusive. To identify the associated genetic variants in
these kindreds, candidate gene sequencing or NGS (e.g., exome sequencing
or whole genome sequencing) can be performed. Caution should be taken
in ascribing sleep phenotypes to variants found in small kindreds by these
approaches, as there is practically no statistical means to substantiate the
hypothesis. Further biomedical and animal experiments are required to
determine the causative role of any particular variant (see Section 4).
4. MODELING HUMAN SLEEP PHENOTYPES IN RODENTS
4.1. Overview
The finding of a rare genetic variant associated with Mendelian autosomal
dominant FASP or FNSS in multiple members of a kindred is a good indi-
cation that it is a causative variant. However, in linkage studies, given the
relative small size of most FASP and FNSS families, it is usually hard to define
chromosomal loci with high lod scores. Thus, there is a possibility that an
identified variant is just in linkage disequilibrium with the actual causative
variant if the sequencing data of the whole locus are not available, as is usu-
ally the case when exons are selectively sequenced. Although identification
of more than one variant in a gene in independent kindreds is considered
strong evidence that the gene is associated with the phenotype, in most cases,
whether the variants identified actually contribute to the sleep phenotypes
often cannot be deduced by genetic information alone. Furthermore, even if
the identified variant contributes to the sleep phenotype, the effect size is not
easily derived. From a strict genetic point of view, the variant cannot be val-
idated without tracking the genotype–phenotype relationship in the future
generations. Therefore, generating mouse lines that faithfully model the
genetic variants associated with FASP and FNSS offers unparalleled oppor-
tunities to determine the causal relationship and to elucidate the
mechanisms.
4.2. Methods
4.2.1 Generation of mouse models
After a variant is identified, its evolutionary conservation is assessed
across several species, especially among mammals. For a coding gene, high
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homology of the polypeptide sequence strongly suggests functional
conservation. Therefore, in order to model a given variant using mouse
models, it is imperative for the identified variant to reside on
residue(s) with high identity across the mammalian species. The resulting
mouse models are highly likely to recapitulate not only the sleep–wake
phenotype but also the alterations in molecular and cellular processes
due to the human variants.
There are several methods to generate mouse models of human genetic
variants, including introduction of Bacterial Artificial Chromosomes
(BACs), traditional knock-in strategies, and new genome editing
approaches, such as CRISPR and ZFN (Gaj, Gersbach, & Barbas, 2013).
The design of the genetic modification should faithfully model the human
variants and remain under transcriptional regulation of endogenous ele-
ments. It is worth considering adding a tag (e.g., GFP or FLAG-tag) trans-
lationally fused to the gene of interest, as it may help track the expression of
the modified gene and facilitate downstream studies, though it should be
noted that the addition of tag may affect the expression of the gene. The
BAC, targeting construct or recombination donor fragment, should be fully
sequenced to make sure that there is no unintended mutation and that the
tag is in-frame. When using new generation editing tools, whole genome
sequencing of the edited embryonic stem cells is strongly recommended
to rule out the possibility of off-target effect. For details of individual
methods, we refer the readers to several excellent papers (Asrican et al.,
2013; Cai, Bak, & Mikkelsen, 2014; Johansson et al., 2010; Ran et al.,
2013; Wang, Zhao, Leiby, & Zhu, 2009).
4.2.2 Sleep phenotyping of mouse models
As discussed in Section 2.2.3, one of the difficulties with phenotyping
human subjects is to obtain accurate measure of circadian period (τ) and
sleeping pattern in laboratory settings. In contrast, it is relatively easy to
breed genetically homogeneous mice and to assess sleep phenotypes using
the same set of parameters for quantifying human sleep. In this regard, sev-
eral reports have exemplified the feasibility of utilizing mouse models to
study human sleep phenotypes (Hasan et al., 2014; He et al., 2009; Xu
et al., 2005, 2007). In addition, since there are only a few affected individuals
phenotypically verified in most FASP and FNSS families, it is usually not
possible to ascertain statistical significance in these measurements. There-
fore, a thorough sleep phenotyping of mouse models is vital in establishing
the effect of potential causative variants.
319Genetics of Human Sleep Behavioral Phenotypes
Author's personal copy
Rodents exhibit innate wheel-running behavior with running wheels
available in their cages. Recordings of wheel running are good measures
of activity patterns and are also proxies for sleeping patterns. The
wheel-running activity can be analyzed using CLOCKLAB software
(Coulbourn Instruments) and is usually in alternating active phase (α) and
rest phase (ρ). Under 12-h light/dark cycle (12L:12D), α and ρ are proxi-
mally the dark and light phase of the cycle, respectively, for nocturnal mice.
In this setting, mice carrying genetic variants associated with FNSS are
expected to have a longer α, whereas those carrying FASP-associated vari-
ants have active phase (α) comparable to wild type. On the other hand, FASP
models are expected to start their activities before the onset of dark phase, if
they are to resemble human FASP subjects. However, light masking effect,
which is the suppression of activity by photic cues independent of circadian
rhythms, may obscure determination of the bona fide wake time in this set-
ting. To minimize light masking effect, skeleton photoperiod protocol can
be employed in which mice are given 1-h light pulses at the beginning and
end of the previous light phase (1L:10D:1L:12D) but are otherwise held in
darkness (Dallmann, DeBruyne, & Weaver, 2011; Pittendrigh & Daan,
1976). In this protocol, skeleton photoperiods are sufficient to entrain the
mice but greatly reduce light masking, therefore revealing the possible phase
advancement that would otherwise be suppressed under 12L:12D. Further-
more, as demonstrated previously, some FASP subjects harbor variants caus-
ing a shortened circadian cycle (Xu et al., 2007). To test this hypothesis
without the interference of light, circadian period (τ) should be evaluated
in FASP murine models subject to free-running condition in constant dark-
ness (D/D). τ is measured as the length between the onset of one active
period to the next (i.e., the sum of α and ρ in one cycle).
To definitively measure sleeping patterns, EEG should be employed (He
et al., 2009; Huber et al., 2000). Although light masking effect obscures the
deduction of true sleep–wake patterns from actogram, sleep can be precisely
defined by the power density of different wavelengths on EEG (Hughes,
1990; Pisarenco, Caporro, Prosperetti, & Manconi, 2014). Quantifying
the duration and number of NREM and rapid eye movement (REM) sleep
bouts gives a good estimate of the stability of sleep. In addition, as described
in Section 2.2.3, δ power during NREM allows the determination of sleep
quality (Huber et al., 2000; Pisarenco et al., 2014). FASP mouse models are
predicted to have drastically decreased sleep bouts a few hours before the
onset of dark phase, whereas FNSS model mice are expected to have less
total sleep time during the 24 h L/D cycle as well as in the light phase.
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One characteristic of natural short sleepers is their relative resistance to
sleep deprivation and their decreased demand for rebound sleep. In order to
assess these aspects in FNSSmurine models, mice subject to 6 h of sleep dep-
rivation in the first half of a light phase are monitored for changes in sleep
duration and power density in the second half of the light phase and dark
phase. As exemplified in the study of DEC2/BHLHE41 P384R mice
(He et al., 2009), FNSS models are expected to have less rebound sleep
and may have less power density in delta or theta waves in their NREM
and REM sleep, respectively, during the recovery period. It is worth noting
that in human subjects, a better conserved motor and cognitive performance
after sleep deprivation is used as a sign of resistance to sleep deprivation
(Basner, Rao, Goel, & Dinges, 2013). Along this line, natural short sleepers
need less sleep than normal individuals to restore to similar levels of cognitive
function. Therefore, tests designed to examine motor control (e.g., rotor
rod) and cognitive function (e.g., working memory test) can be performed
in FNSS mice to help further establish their face validity for modeling
human phenotypes.
5. CONCLUDING REMARKS
Intense human genetic investigations for various diseases during the
past few decades have revolutionized biomedical research and significantly
illuminated our understanding of many ailments. These research endeavors
have built a solid methodological foundation for the studies of human
behavioral traits, such as the sleep phenotypes discussed in this chapter. Nev-
ertheless, the field of human behavioral traits remains in its infancy. Major
obstacles include difficulties in defining the boundaries of phenotypic var-
iation for a specific trait, analyzing the contribution of genetic components
apart from external influences, and delineating the molecular network reg-
ulating a trait. These obstacles, though similar to those in studying disease
mechanism, are nevertheless more profound and have to be overcome by
intelligent efforts. Here we describe the general experimental flow from
identifying kindreds with sleep phenotypes to modeling of identified
sleep-associated genetic variants in mice. We hope the investigation of
human sleep behavioral phenotypes will represent a step forward in deci-
phering genetic architecture of behavioral traits. Together with the innova-
tion of cutting-edge technologies, we have high expectations for the field of
human behavioral traits to mature rapidly over the next decade.
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